Market Access Events & Heor Events
“Market Access & Health Economics and Outcome Event List” is your go-to destination for Market Access & HEOR event listings. Our platform is designed to update skilled professionals with top meetings in the industry, facilitating the perfect match. Explore our constantly updated database to discover your next meeting in influencing market strategies and unlocking global business opportunities.


The London Biotechnology Show 2025 is scheduled for June 18-19, 2025, at ExCeL London. This premier event aims to expedite the progress of biotechnology, revolutionizing the medical and healthcare sectors both regionally and globally.
The second edition of the London Biotechnology Show will offer participants an exceptional experience to discover the latest technological advancements and groundbreaking offerings. Attendees will engage in high-level discussions, sharing deep industry insights and exploring ways to broaden the scope of red biotechnology worldwide.
The conference will feature top-tier speakers and expert panels discussing key advancements in red biotechnology. Topics include pharmaceutical biotechnology, molecular diagnostics, regenerative medicine, agri-tech, food tech, and environmental sustainability. Additional focus areas include genomics, medical devices, digital health, nutraceuticals, and biostimulants, highlighting their impact on healthcare and innovation.

As a trusted media partner, Market Access Today (MAT) will actively participate in the London Biotechnology Show 2025. MAT will cover key sessions, feature expert insights, and provide real-time updates from the event. Through exclusive interviews, in-depth articles, and event highlights, MAT will deliver the most important discussions in biotechnology directly to its audience.
In a rapidly evolving biotechnology landscape, the London Biotechnology Show 2025 offers an exceptional platform to connect, share insights, and drive change. Mark your calendar for June 18-19, 2025, and join Market Access Today and other global leaders in London for a transformative experience in biotechnology.
London Biotechnology Show Levels Up with Industry Pioneers in Exhibitor Lineup, Hosted Buyer Programme
LONDON, UK – March 19: The much-anticipated second annual edition of the Biotechnology Show continues to attract industry giants, creating a powerful platform for innovation, collaboration, and deal-making. With an expanded roster of exhibitors and an enhanced buyer programme, this year’s edition promises to be a game-changer for industry professionals seeking strategic partnerships and business growth.
Among the leading biotech organisations, innovators and solution providers joining the show, are Discovery Park, Thistle Scientific, Haier Biomedical UK Ltd, Ellab, Mathys & Squire, Cool Repair System, Homogenising Systems Ltd, Merck, nNano, ZAGENO, and UPG International.
The exhibition floor will also spotlight other innovative companies such as Stratagem IPM, LI-Cor Bioscience Ltd, Restore Harrow Green, NIHR, FORMULATRIX, Clarity Compliance Solutions, Brookhouse, BRAND Scientific, Synbiosis, LAUDA Technology, Carterra, ProteoGenix, Life4sciences, Adelphi Healthcare Packaging, IKA, Appleton Woods, Firefinch Software, Integra Biosciences, Exeter Science Park, Miltenyi Biotec, Sterilem Bioscience, Eppendorf, Bishop Simon, LS Scientific, Guardtech Group, Orion GXP Consulting, Fieldfare Consulting, Oxartis, All Med Pro, and INDICRO, highlighting promising ventures with the potential to drive future biotech breakthroughs.
Link to the entire list of exhibitors : https://tinyurl.com/2f744r5h
Recognising the power of collaboration, #LBS25’s has added a Hosted Buyer Programme offering attendees and participants a unique opportunity to connect with sponsors and exhibitors through pre-arranged, one-on-one meetings. This tailored matchmaking approach enables biotech professionals to expand their networks, discover complementary solutions, and establish valuable partnerships.
Additionally, the show will host an insightful conference packed with thought-provoking keynote speeches, interactive discussions, and panel sessions. Attendees will gain insights into groundbreaking topics such as gene editing, regenerative medicine, pharmaceuticals, bioinformatics, medical devices, biomedical engineering, biotechnology in agriculture, and the latest in digital health. This year’s program not only delves into emerging trends but also provides actionable strategies for professionals shaping the future of biotechnology.
Ready to deliver on these crucial topics, the conference features an exceptional lineup, including representatives from leading organizations such as Novo Nordisk, Microsoft, Bayer Pharmaceuticals, the Medicines and Healthcare products Regulatory Agency, Genomics England, and AstraZeneca. Notable participants include:
● Andrew Miles – Multicultural Executive & Leader in Life Sciences and Technology – Google
● Dr. Bryn Roberts – Global Head of Data, Analytics & Research – Roche Information Solutions
● Jakob E. Larsen – Target Discovery Project Director, Novo Nordisk
● Jimmy (Dimitrios) Toulas – World and Commercial Data Director, Pfizer
● Thomas Balkizas – Senior Director Life Sciences – Microsoft
● Sadegh Mohammadi – Head of Computer Vision and Sound Analysis – Bayer Pharmaceuticals
● Mark Davies – Chief Health Officer – IBM
● Dr. James Duboff – Strategic Partnerships Director – Genomics England
● Dr. Bryn Roberts – Global Head of Data, Analytics & Research – Roche Information Solutions
● Kingyin Lee – Head of Clinical Trials – Medicines and Healthcare products Regulatory Agency
● Prof. Ioanna Nixon – Clinical Director Oncology – NHS Greater Glasgow and Clyde
● Click to Check the Entire List of Speakers.
Don’t miss out on this extraordinary opportunity to witness the forefront of biotech innovation. Register now to secure your place at #LBS25 and connect with the industry’s most influential leaders.
For further inquiries, please contact:
Muhammad Younis PR & Communications Lead, London Biotechnology Show [email protected]
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.